SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, a pioneer in the emerging field of digital therapeutics, today announced the National Association of Chronic Disease Directors (NACDD) has selected its flagship product, Prevent, an online program to fight prediabetes, as a premier solution for patients seeking an online Diabetes Prevention Program (DPP).
The mission of the NACDD is to work with public health departments, associations and private partners across the United States to prevent and control chronic disease. One of NACDD’s areas of focus is the prevention of type 2 diabetes. People with diagnosed diabetes, on average, have medical expenditures approximately 2.3 times higher than those without diabetes. Thirty-seven percent of American adults have prediabetes (the clinical precursor to type 2 diabetes), and without lifestyle changes to improve their health, 15% to 30% of those will develop type 2 diabetes within five years.
“The rise of type 2 diabetes is a critical issue facing our country,” said John Robitscher, CEO of the NACDD. “Our goal is to help educate our members and the public about prediabetes and help those at risk find and enroll in The National Diabetes Prevention Program in a way that will be most effective for them. We were drawn to Omada’s Prevent program because of the accessibility and cost-effectiveness of the digital therapeutics approach. It offers a proven, best in class DPP through a simple and enjoyable online platform that is available to anyone, anywhere at an affordable price point.”
“The NACDD’s endorsement of Prevent is a tremendous validation of how digital therapeutics can revolutionize behavioral medicine and help combat chronic disease at scale,” said Sean Duffy, Co-Founder and CEO of Omada Health. “Prevent was designed to be as enjoyable, intuitive, and convenient as possible, and we couldn’t be more thrilled to be working with the NACDD to provide the healthcare community an affordable new option to help fight type 2 diabetes in our country.”
Prevent is an online diabetes prevention program based on the National Diabetes Prevention Program, a large randomized clinical trial by the NIH. The 16-week online Prevent program, which is currently being sponsored by a variety of employers and health plans, has published outcomes in the leading medical journal Diabetes Educator and is credited for helping patients lose weight and make the sort of lifestyle changes shown to help reduce the risk of type 2 diabetes. Prevent is based on established behavioral change science, and integrates seamlessly into everyday life to achieve best-in-class patient engagement. The program is guided by dedicated health coaches and offers community social support, meaning every participant has real people, in real-time, monitoring their progress and offering 24/7 feedback and ensuring accountability. Omada Health is committed to pay-for-performance models for digital therapeutics, and the cost of Prevent is outcomes based with program costs directly tied to patient success.
About the National Association of Chronic Disease Directors
The National Association of Chronic Disease Directors (NACDD) is a non-profit, public health organization committed to serve the chronic disease program directors of each state and U.S. jurisdiction. Founded in 1988, NACDD connects more than 4,000 chronic disease practitioners to advocate for preventive policies and programs, encourage knowledge sharing and develop partnerships for health promotion. Since its founding, NACDD has been a national leader in mobilizing efforts to reduce chronic diseases and their associated risk factors through state and community-based prevention strategies.
About Omada Health
Omada Health is pioneering a new class of medicine called digital therapeutics. The company believes that technology will redefine behavioral medicine and bring a new future to the 75% of Americans who will die prematurely from preventable lifestyle-related chronic conditions. Omada Health drives positive health outcomes through a combination of immersive digital experiences. The company’s flagship product, Prevent, is the first-ever online diabetes prevention program for the general public and is based on the landmark Diabetes Prevention Program (DPP) clinical trial. Prevent customers include major organizations, integrated delivery networks and health plans such as Kaiser Permanente, Blue Cross and Blue Shield of Louisiana, and Stanford Hospital & Clinics. For more information, visit http://www.omadahealth.com and http://preventnow.com.